0001140361-17-012580.txt : 20170317 0001140361-17-012580.hdr.sgml : 20170317 20170317164545 ACCESSION NUMBER: 0001140361-17-012580 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170317 DATE AS OF CHANGE: 20170317 EFFECTIVENESS DATE: 20170317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTRICITY INC. CENTRAL INDEX KEY: 0001630113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 472548273 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-282869 FILM NUMBER: 17698609 BUSINESS ADDRESS: STREET 1: 75 INTERNATIONAL BLVD., SUITE 300 CITY: TORONTO STATE: A6 ZIP: M9W 6L9 BUSINESS PHONE: (416) 214-3678 MAIL ADDRESS: STREET 1: 75 INTERNATIONAL BLVD., SUITE 300 CITY: TORONTO STATE: A6 ZIP: M9W 6L9 FORMER COMPANY: FORMER CONFORMED NAME: METASOLUTIONS, INC. DATE OF NAME CHANGE: 20150107 D 1 primary_doc.xml X0707 D LIVE 0001630113 BIOTRICITY INC. 275 Shoreline Drive Suite 150 Redwood City CA CALIFORNIA 94065 (416) 214-3678 NEVADA None METASOLUTIONS, INC. Corporation true 2012 Waqaas Al-Siddiq 275 Shoreline Drive Suite 150 Redwood City CA CALIFORNIA 94065 Executive Officer Director CEO/Chairman Biotechnology No Revenues 06b false 2017-03-07 false true true false 50000 Corinthian Partners LLC 38912 None None 850 Third Avenue Suite 16C New York NY NEW YORK 10022 FL FLORIDA OR OREGON WA WASHINGTON false 8000000 1232000 6768000 Option to increase by additional $12 million pursuant to overallotment. false 0 100000 true 0 $100,000 assumes the minimum offering is sold. The placement agent will receive up to $800,000 if the maximum offering is sold (not including overallotment). 0 false BIOTRICITY INC. /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq CEO/Chairman 2017-03-17